DRRX DURECT CORP Other Situations 8-K Filing 2023 - Phase 2a trial data accepted by journal DURECT Corp announced that additional data from its Phase 2a trial has been accepted by a peer-reviewed journal.Get access to all SEC 8-K filings of the DURECT CORP